BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 22, 2026
Home » Authors » John Brosky

Articles by John Brosky

Elekta inks $100M deal with Genesiscare, grabbing larger market share in Australi

April 4, 2016
By John Brosky
PARIS – Elekta Instrument AB closed a strategic partnership agreement it values at $100 million with radiation oncology specialist Genesiscare Ltd. Elekta's Chief Commercial Officer Ian Alexander told Medical Device Daily, "This is the largest deal we have ever closed, and it is significant on a number of levels."
Read More

Nexstim to bring failed sham trial for stroke device to FDA, hoping for success

April 1, 2016
By John Brosky
PARIS – Here's a puzzler that will leave you scratching your head. Say a therapeutic treatment fails to meet the end point in a clinical trial because the sham group did almost as well as the target patient group. Do you take the device to the FDA with a 510k denovo application?
Read More

Tappy says to reach value in med-tech, one must go all the way with a firm

March 29, 2016
By John Brosky

Investors pump fresh cash into dedicated med-tech venture fund

March 28, 2016
By John Brosky
Last week, Endeavour Vision SA from Geneva, Switzerland announced it had closed the largest venture capital fund ever to be dedicated exclusively to medical technologies. Medtech Growth Limited Partners holds €250 million ($279 million) to be focused on late-stage medical device start-ups, and more specifically, those with a digital health component in their products.
Read More

MIT polymer raises $25 million in early stage deal for Gecko Biomedical

March 23, 2016
By John Brosky
PARIS – Would you pay $25 million to come in on the ground floor of Super Glue?
Read More

MDxhealth aims to disrupt U.S. prostate market for biopsy, MRI exams

March 21, 2016
By John Brosky

Roche deal pumps up Cellnovo prospects for insulin delivery

March 16, 2016
By John Brosky

The need for speed drives MRI sales with accelerated workflow

March 7, 2016
By John Brosky

Cloud computing to break grip of PACS on medical imaging

March 4, 2016
By John Brosky
VIENNA – Ready or not, radiology is going to the cloud. And radiologists are definitely not ready, stubbornly continuing with unstructured reports that defy data analytics and hospital-based dedicated workstations for picture archiving and communication systems (PACS).
Read More

Tomosynthesis still stuck at starting gate as screening tool

March 3, 2016
By John Brosky
Previous 1 2 … 9 10 11 12 13 14 15 16 17 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing